AD/PD 2019, the 14th International Conference on Alzheimer's and Parkinson's Diseases
The AD/PDTM meeting will take place in Lisbon, Portugal, one of the most classical cities in Europe. The conference will build on the well-earned reputation of previous AD/PDTM Conferences. The ground breaking series of Alzheimer's and Parkinson's Diseases Conferences attract international medical and scientific professionals worldwide.
The Conference is at the forefront of unraveling the mechanisms and improving the treatment of Alzheimer's, Parkinson's and other related neurodegenerative diseases. AD/PDTM Conferences uniquely combine distinct neurodegenerative diseases in one setting and examine their similarities and differences; a strong focus is mechanisms of disease, prevention, and therapy.
The remarkable success of the series of AD/PDTM Conferences is evident from the progressive increases from one Conference to the next, in the number of participants, over 3,217 in Vienna in 2017, the number of countries represented, 66 in Vienna, and the ratio of individuals below the age of 35 to that of the rest of the group. At AD/PDTM 2019 in Lisbon we anticipate an attendance of more than 3500 participants.
Assessment of potential neuroprotective effects of alkaloids in a human dopaminergic in vitro model of Parkinson's Disease